MA

Meltwind Advisory

Europe, Cambridgeshire, United Kingdom, Cambridge

Description

Meltwind Advisory is an investment firm.

Investor Profile

Meltwind Advisory has made 26 investments, with 5 in the past 12 months and 15% as lead.

Stage Focus

  • Seed (50%)
  • Pre Seed (15%)
  • Series A (15%)
  • Series Unknown (12%)
  • Convertible Note (4%)
  • Series C (4%)

Country Focus

  • United Kingdom (92%)
  • United States (8%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Life Science
  • Machine Learning
  • Artificial Intelligence (Ai)
  • Analytics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Meltwind Advisory frequently co-invest with?

Martlet Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Wren Capital
Europe, England, United Kingdom, London
Co-Investments: 3
Business Growth Fund
Europe, England, United Kingdom, London
Co-Investments: 3
UK Innovation & Science Seed Fund
Europe, Oxfordshire, United Kingdom, Harwell
Co-Investments: 3
Cambridge Angels group
Europe, England, United Kingdom, London
Co-Investments: 5
Cancer Research Horizons
Europe, England, United Kingdom, London
Co-Investments: 2
Kindred Capital
Europe, England, United Kingdom, London
Co-Investments: 2
O2h Ventures
Europe, Cambridgeshire, United Kingdom, Hauxton
Co-Investments: 8
Octopus Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
IQ Capital
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 3

Which angels does Meltwind Advisory often collaborate with?

PG
Europe, England, United Kingdom, London
Shared Deals: 1
DC
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Meltwind Advisory?

Natrox

Cambridge, Cambridgeshire, United Kingdom

Natrox is a wound care company that offers innovative technologies for healthcare professionals for chronic wounds.

Health CareMedicalMedical Device
Series CDec 2, 2024
Amount Raised: $33,000,000
Shift Bioscience

Cambridge, Cambridgeshire, United Kingdom

Simulation guided target discovery for age-linked diseases

BiopharmaBiotechnologyMachine LearningPharmaceutical
SeedOct 15, 2024
Amount Raised: $16,331,095
NanoSyrinx

Coventry, Coventry, United Kingdom

NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick’s Medical School.

BiotechnologyMedicalTherapeutics
Series ASep 10, 2024
Amount Raised: $13,079,777
Infinitopes

Oxford, Oxfordshire, United Kingdom

Infinitopes is developer of vaccines for the treatment of cancer.

Biotechnology
SeedApr 30, 2024
Amount Raised: $15,985,813
Qureight

Cambridge, Cambridgeshire, United Kingdom

Qureight is an imaging analytics company.

AnalyticsHealth CareMachine Learning
Series AApr 15, 2024
Amount Raised: $8,463,427
Tagomics

Cambridge, Massachusetts, United States

Tagomics transform disease diagnosis through comprehensive multitopic profiling.

BiotechnologyLife Science
SeedFeb 21, 2024
Amount Raised: $8,467,582
ViaNautis

Cambridge, Cambridgeshire, United Kingdom

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

BiopharmaBiotechnologyMedical
Series ANov 13, 2023
Amount Raised: $24,558,590
Kuano

London, England, United Kingdom

Kuano provides innovative quantum and AI solutions for drug discovery and design.

Artificial Intelligence (AI)Biotechnology
SeedSep 12, 2023
Amount Raised: $2,248,426
NK:IO

London, England, United Kingdom

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.

BiotechnologyLife ScienceTherapeutics
SeedJul 25, 2023
Amount Raised: $1,547,243
Scarlet Therapeutics

Bristol, Bristol, City of, United Kingdom

Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.

BiotechnologyTherapeutics
SeedMay 23, 2023